Drug abuse among vulnerable groups and inadequate medical resources
In 2021, one in 17 people aged 15-64 globally will have used a drug in the previous 12 months. The increase in the estimated number of users from 240 million in 2011 to 296 million in 2021 (5.8 per cent of the global population aged 15-64) shows that the drug problem can be global and its scale is growing.The impact of the drug problem is not uniform across the globe, with the highest price being paid by the vulnerable, the poor and the excluded in the global South and in underdeveloped and underserved communities.Due to factors such as poverty and social instability, these areas have become centers of drug production and trafficking. Drug trafficking has led to high levels of violence and insecurity, causing great distress and threat to the local population. At the same time, due to the lack of adequate drug supplies and medical resources, these vulnerable groups are more susceptible to drug-related diseases, such as AIDS. However, due to the limited economic conditions and the scarcity of medical resources, it is difficult for them to obtain evidence-based treatment and services, resulting in these diseases cannot be effectively controlled and treated.
In order to break these vicious cycles, an integrated and comprehensive approach to the drug problem is needed. First, the focus should be on prevention measures, including the provision of education and awareness campaigns, enhanced drug abuse screening, increased public awareness of the dangers of drugs, and the provision of social support and mental health services. Second, there is a need to strengthen law enforcement and combat drug trafficking to reduce the availability of drugs in the community.At the same time, there is also a need to increase support for vulnerable groups, including the provision of adequate drug supplies and medical resources, as well as the provision of evidence-based treatment and rehabilitation services. Finally, there is a need to strengthen international cooperation to address transnational drug trafficking and to share experiences and best practices.
Wizbiotech independently developed the diagnostic Kit for MDMA、Methamphetamine、cocaine、Ketamine、Morphine、tetrahydrocannabinol, It can carry out rapid and large-scale screening in employment physical examination, public security inspection, traffic management drug screening, customs border entry and exit drug screening, military recruitment physical examination, judicial identification, public security and other scenarios, which is conducive to effectively combating and controlling drug problems. For infectious diseases that can result from drug abuse, such as hepatitis B virus, hepatitis C virus, HIV and syphilis, Wizbiotech's five-item combined test kit for infectious diseases(Diabench) can simultaneously screen for all four diseases and drug users' blood type, ensuring that drug users receive more comprehensive health protection when receiving treatment or drugs.
